[ Price : $8.95]
Federal Register notice: FDA awards a priority review voucher to Leadiant Bioscience after determining that rare disease drug Revc...[ Price : $8.95]
The Council on Economic Advisors says FDA efforts to control drug prices are providing savings to consumers.[ Price : $8.95]
FDA publishes a draft guidance on legal requirements for drug supply chain verification systems.[ Price : $8.95]
FDA approves an updated label for Novo Nordisks Saxenda to add cardiovascular risk data for the drugs active ingredient from the L...[ Price : $8.95]
FDA issues a white paper outlining issues to be discussed at a December workshop on the distinctions between medical device servic...[ Price : $8.95]
FDA clears a Rocky Mountain Orthodontics 510(k) for Orthocaps, a transparent and removable appliance for correcting tooth malposit...[ Price : $8.95]
Pfizer and Lilly say a Phase 3 trial of their novel osteoarthritis monoclonal antibody met all three co-primary efficacy endpoints...[ Price : $8.95]
FDA approves Genentechs Xofluza (baloxavir marboxil) for treating acute, uncomplicated influenza in people 12 years of age and old...